437701-80-9

Usage

Uses

Used in Pharmaceutical Synthesis:
1H-Pyrazole-4-carboxamide is used as a key intermediate in the synthesis of pharmaceuticals for its ability to be incorporated into a variety of drug molecules, enhancing their therapeutic properties and effectiveness.
Used in Tuberculosis Treatment:
1H-Pyrazole-4-carboxamide is used as a potential therapeutic agent for the treatment of tuberculosis, due to its researched properties that may contribute to the management and treatment of this infectious disease.
Used in Antifungal Applications:
1H-Pyrazole-4-carboxamide is used as an antifungal agent, leveraging its potential to combat fungal infections, thereby serving as a crucial component in antifungal medications.
Used in Antibacterial Applications:
1H-Pyrazole-4-carboxamide is used as an antibacterial agent, harnessing its potential to inhibit bacterial growth, making it a candidate for development in antibacterial drugs.
Used in Medicinal Chemistry Research:
1H-Pyrazole-4-carboxamide is used as a research compound in medicinal chemistry, where it is explored for its potential to contribute to the discovery of new drugs and therapeutic agents for various medical conditions.

Upstream product

• 1234737-38-2 N-(hydrazonomethyl)-1H-pyrazole-4-carboxamide 
• 37622-90-5 4-ethoxycarbonylpyrazole 
• 37718-11-9 1H-pyrazole-4-carboxylic acid 

Downstream Products

• 1234737-53-1 4-aminocarbonyl-N-[4-chloro-3-(trifluoromethyl)phenyl]-1H-pyrazole-1-acetamide 
• 1234737-55-3 4-aminocarbonyl-N-(2,4-dichlorophenyl)-1H-pyrazole-1-acetamide 
• 1234737-54-2 4-aminocarbonyl-N-(4-methylphenyl)-1H-pyrazole-1-acetamide 
• 1234737-56-4 4-aminocarbonyl-N-(4-chlorophenyl)-1H-pyrazole-1-acetamide 

Relevant academic research and scientific papers

OXAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH

The present invention is directed to certain oxazole derivatives which are useful as inhibitors of Fatty Acid Amide Hydrolase (FAAH). The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including osteoarthritis, rheumatoid arthritis, diabetic neuropathy, postherpetic neuralgia, skeletomuscular pain, and fibromyalgia, as well as acute pain, migraine, sleep disorder, Alzheimer Disease, and Parkinson's Disease.

A novel synthetic approach towards pyrazole-4-carboxamides using N-(3-(dimethylamino)-2-formylacryloyl)formamide

A novel synthesis of pyrazole-4-carboxamides is reported. The reaction of N-(3-(dimethylamino)-2-formylacryloyl)formamide, an intermediate obtained by Vilsmeier-Haack formylation of acetonitrile, with hydrazine hydrate or monosubstituted hydrazines provid

OXAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH

The present invention is directed to certain oxazole derivatives which are useful as inhibitors of Fatty Acid Amide Hydrolase (FAAH). The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including osteoarthritis, rheumatoid arthritis, diabetic neuropathy, postherpetic neuralgia, skeletomuscular pain, and fibromyalgia, as well as acute pain, migraine, sleep disorder, Alzeimer Disease, and Parkinson's Disease.

PURINE DERIVATIVES AS ADENOSINE AL RECEPTOR LIGANDS

Compounds of formula (I), their preparation and use as pharmaceuticals (I), wherein X, Y, and Z are as defined herein.

DERIVATIVES OF IMIDAZO (1,2-A) PYRIDINE USEFUL AS MEDICAMENTS FOR TREATING GASTROINTESTINAL DISEASES

This invention relates to newly identified imidazopyridine compounds of formula (I), to the use of such compounds in therapy and to their production.